Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study

被引:47
作者
Nakayama, Masaaki [1 ,2 ]
Sato, Toshinobu [3 ]
Miyazaki, Mariko
Matsushima, Masato [4 ]
Sato, Hiroshi [5 ]
Taguma, Yoshio [3 ]
Ito, Sadayoshi
机构
[1] Tohoku Univ, Grad Sch Med, Ctr Adv Integrated Renal Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Fukushima Med Univ, Sch Med, Fukushima, Japan
[3] Sendai Shakaihoken Hosp, Kidney Ctr, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Clin Res, Tokyo, Japan
[5] Tohoku Univ, Grad Sch Pharmacol, Dept Clin Pharmacol, Sendai, Miyagi 9808574, Japan
关键词
cardiovascular disease; chronic kidney disease; hypertensive nephropathy; GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; MECHANISMS; DYSLIPIDEMIA; PATHOGENESIS; PROTEINURIA; CHILDREN; OUTCOMES; STRESS; STROKE;
D O I
10.1038/hr.2011.96
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To examine the clinical significance of hypertensive nephropathy (HN) among non-diabetic chronic kidney disease (CKD) patients. The study comprised 2692 CKD patients recruited from 11 outpatient nephrology clinics; these included 1306 patients with primary renal disease (PRD), 458 patients with HN, 283 patients with diabetic nephropathy (DN) and 645 patients with other nephropathies (ONs). All patients fulfilled the criteria of CKD, with a persistent low estimated glomerular filtration rate (eGFR) <60 ml min(-1) per 1.73 m(2) or proteinuria as determined by a urine dipstick test. The risk factors for cardiovascular disease (CVD), such as ischemic heart disease, congestive heart failure and stroke; all-cause mortality; and progression to end-stage renal failure (dialysis induction) were analyzed using a Cox proportional hazards model in each group. During a mean follow-up period of 22.6 months from recruitment, 100 patients were lost to follow-up and 192 patients began chronic dialysis therapy. A total of 115 CVD events occurred (stroke in 37 cases), and 44 patients died. Regarding CVD events and death, there were significant differences in the hazard ratios (HRs) for the groups of patients with different underlying renal diseases as determined by both univariate and multivariate analysis adjusted for confounding factors including estimated glomerular filtration rate: PRD, 1.0 (reference); HN, 3.33 (95% confidence interval, 1.82-6.09); DN, 5.93 (2.80-12.52); and ON, 2.22 (1.22-4.05). However, there were no differences in the hazard ratio for dialysis induction for the groups of patients with different underlying renal diseases. HN is associated with an increased risk of CVD events and death among non-diabetic CKD patients, which highlights the clinical significance of HN. Hypertension Research (2011) 34, 1106-1110; doi:10.1038/hr.2011.96; published online 28 July 2011
引用
收藏
页码:1106 / 1110
页数:5
相关论文
共 39 条
[1]   Chronic kidney disease associated mortality in diastolic versus systolic heart failure: A propensity matched study [J].
Ahmed, Ali ;
Rich, Michael W. ;
Sanders, Paul W. ;
Perry, Gilbert J. ;
Bakris, George L. ;
Zile, Michael R. ;
Love, Thomas E. ;
Aban, Inmaculada B. ;
Shlipak, Michael G. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03) :393-398
[2]   Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients [J].
Barreto, Fellype C. ;
Barreto, Daniela V. ;
Liabeuf, Sophie ;
Meert, Natalie ;
Glorieux, Griet ;
Temmar, Mohammed ;
Choukroun, Gabriel ;
Vanholder, Raymond ;
Massy, Ziad A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (10) :1551-1558
[3]   Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials [J].
Chan, Doris T. ;
Irish, Ashley B. ;
Dogra, Gursharan K. ;
Watts, Gerald F. .
ATHEROSCLEROSIS, 2008, 196 (02) :823-834
[4]   Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials [J].
Cheng, Jun ;
Zhang, Xiaohui ;
Zhang, Wen ;
He, Qiang ;
Tao, Xiaojuan ;
Chen, Jianghua .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (04) :315-322
[5]   Membranous nephropathy in the older adult - Epidemiology, diagnosis and management [J].
Deegens, Jeroen K. J. ;
Wetzels, Jack F. M. .
DRUGS & AGING, 2007, 24 (09) :717-732
[6]  
Dombros N, 2005, NEPHROL DIAL TRANSPL, V20, P3
[7]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[8]   Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum [J].
Glassock, Richard J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (08) :2221-2225
[9]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[10]   The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia [J].
Himmelfarb, J ;
Stenvinkel, P ;
Ikizler, TA ;
Hakim, RM .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1524-1538